These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15855546

  • 1. Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.
    Powis J, McGeer A, Duncan C, Goren R, de Azavedo JC, Bast DJ, Pong-Porter S, Mazzulli T, Green K, Willey B, Low DE.
    Antimicrob Agents Chemother; 2005 May; 49(5):2130-2. PubMed ID: 15855546
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [Abstract] [Full Text] [Related]

  • 5. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS, Diekema DJ, Heilmann KP, Almer LS, Shortridge VD, Zeitler R, Flamm RK, Doern GV.
    Clin Infect Dis; 2003 Feb 01; 36(3):380-3. PubMed ID: 12539083
    [Abstract] [Full Text] [Related]

  • 6. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
    Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA.
    J Infect Dis; 2005 Apr 15; 191(8):1272-9. PubMed ID: 15776373
    [Abstract] [Full Text] [Related]

  • 7. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.
    Albertí S, Cortés G, García-Rey C, Rubio C, Baquero F, García-Rodríguez JA, Bouza E, Aguilar L.
    Antimicrob Agents Chemother; 2005 Jan 15; 49(1):418-20. PubMed ID: 15616324
    [Abstract] [Full Text] [Related]

  • 8. An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.
    Yan SS, Schreckenberger PC, Zheng X, Nelson NA, Harrington SM, Tjhio J, Fedorko DP.
    Diagn Microbiol Infect Dis; 2008 Oct 15; 62(2):205-9. PubMed ID: 18554840
    [Abstract] [Full Text] [Related]

  • 9. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
    Rivera A, Rebollo M, Sánchez F, Navarro F, Miró E, Mirelis B, Coll P.
    Clin Microbiol Infect; 2005 Sep 15; 11(9):759-61. PubMed ID: 16104992
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
    Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S.
    J Antimicrob Chemother; 2012 Nov 15; 67(11):2602-5. PubMed ID: 22815354
    [Abstract] [Full Text] [Related]

  • 12. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
    Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y, Yamamoto N, Kunishima H, Kaku M.
    J Antimicrob Chemother; 2011 Mar 15; 66(3):494-8. PubMed ID: 21172783
    [Abstract] [Full Text] [Related]

  • 13. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman MA, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jun 15; 55(2):119-27. PubMed ID: 16530373
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.
    Pinho MD, Melo-Cristino J, Ramirez M, Portuguese Group for the Study of Streptococcal Infections.
    Antimicrob Agents Chemother; 2010 May 15; 54(5):1769-77. PubMed ID: 20145082
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.
    Canton R, Morosini M, Enright MC, Morrissey I.
    J Antimicrob Chemother; 2003 Dec 15; 52(6):944-52. PubMed ID: 14585861
    [Abstract] [Full Text] [Related]

  • 20. Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy.
    Petrelli D, Di Luca MC, Prenna M, Bernaschi P, Repetto A, Vitali LA.
    Eur J Clin Microbiol Infect Dis; 2014 Feb 15; 33(2):241-4. PubMed ID: 24002218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.